期刊文献+

胞外囊泡与慢性乙型肝炎相关性研究进展

Research progress on the association between extracellular vesicles and chronic hepatitis B
暂未订购
导出
摘要 乙型肝炎病毒持续感染引发的免疫微环境失衡与纤维化进程仍是临床管理难点。近年来,胞外囊泡(EV)作为一种可携带病毒组分与宿主调控分子的纳米级载体,在慢性乙型肝炎(CHB)疾病进展中的调控作用逐渐成为研究热点。EV通过介导细胞间通信,在介导乙型肝炎病毒组分转移、免疫应答调节及肝星状细胞活化与纤维化形成中发挥作用。本文综述EV在CHB相关免疫调控和肝纤维化中作用机制的最新进展,探讨其作为生物标志物或治疗靶点的潜力,为CHB开发基于EV的新型诊断与治疗策略提供新思路。 The persistent immune microenvironment imbalance and fibrogenesis triggered by hepatitis B virus infection remain major clinical challenges.In recent years,extracellular vesicle(EV)as nanoscale carriers capable of transporting viral components,and host regulatory molecules,have attracted increasing attention for their regulatory roles in the progression of chronic hepatitis B(CHB).EV plays a role in mediating the transfer of hepatitis B virus components,immune response regulation,activation and fibrosis formation of hepatic stellate cells by mediating intercellular communication.This article reviews the latest progress on action mechanism of EV in CHB associated immune regulation and liver fibrosis,explores its potential as a biomarker or therapeutic target,and provides new ideas for the development of novel diagnostic and therapeutic strategies for CHB based on EV.
作者 徐天宇 陈尹 丁钰仁 罗新华 洪国祜 XU Tianyu;CHEN Yin;DING Yuren;LUO Xinhua;HONG Guohu(College of Clinical Medicine,Guizhou Medical University,Guizhou Province,Guiyang 550001,China;Department of Infectious Diseases,College of Clinical Medicine,Guizhou Medical University,Guizhou Province,Guiyang 550001,China;Department of Hepatology and Infectious Diseases,Guizhou Provincial People’s Hospital,Guizhou Province,Guiyang 550002,China)
出处 《中国医药导报》 2025年第26期192-196,F0003,共6页 China Medical Herald
关键词 胞外囊泡 慢性乙型肝炎 肝纤维化 免疫调控 Extracellular vesicles Chronic hepatitis B Liver fibrosis Immune regulation
  • 相关文献

参考文献5

二级参考文献41

  • 1Peng Hu,Jia Shang,Wenhong Zhang,Guozhong Gong,Yongguo Li,Xinyue Chen,Jianning Jiang,Qing Xie,Xiaoguang Dou,Yongtao Sun,Yufang Li,Yingxia Liu,Guozhen Liu,Dewen Mao,Xiaoling Chi,Hong Tang,Xiaoou Li,Yao Xie,Xiaoping Chen,Jiaji Jiang,Ping Zhao,Jinlin Hou,Zhiliang Gao,Huimin Fan,Jiguang Ding,Dazhi Zhang,Hong Ren.HBsAg Loss with Peg-interferon Alfa-2a in Hepatitis B Patients with Partial Response to Nucleos(t)ide Analog:New Switch Study[J].Journal of Clinical and Translational Hepatology,2018,6(1):25-34. 被引量:102
  • 2Xie-Er Liang,Yong-Peng Chen.Clinical Application of Vibration Controlled Transient Elastography in Patients with Chronic Hepatitis B[J].Journal of Clinical and Translational Hepatology,2017,5(4):368-375. 被引量:13
  • 3龚文胜,叶素丹,陈宁.121例肝硬化患者血小板聚集功能观察[J].现代医院,2005,5(3):21-22. 被引量:4
  • 4Barrett NE, Holbrook L,Jones S, et al. Future innovations in anti-platelet therapies[J]. BrJ Phannacol, 2008,154(5): 918-939.
  • 5Bonkovsky HL, Naishadham D, Lambrecht RW, et al. Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis C[J] . Gastroenterology, 2006,131 (5) : 1635-1638.
  • 6Mayo MJ, MosbyJM,Jeyarajah R, et al. The relationship between hepatic immunoglobulin production and CD154 expression in chronic liver diseases[J]. Liver Int, 2006,26 (2): 187-196.
  • 7GengJG, Chen M, Chou KC. P-selectin cell adhesion molecule in inflammation, thrombosis, Cancer growth and metastasis[J]. Current Med Chern, 2004,11 (16) :2153-2160.
  • 8Lang P A, Contaldo C, Georgiev P, et al. Aggravation of viral hepatitis by platelet-derived serotonin[J]. Nat Med, 2008,14 (7): 756-761.
  • 9Beom KK, Sung AK , Young NP, et al. Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B[J]. Liver Int , 2007,27 (7) : 969-976.
  • 10Fabris C, Smime C, Foniutto P, et al. Assessment of liver fibrosis progression in patients with chronic hepatitis C and normal alanine aminotransferase values: The role of AST to the platelet ratio index[J]. Clin Biochem, 2006, 39 ( 4 ) : 339- 343.

共引文献533

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部